Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients
F Perticone,
R Ceravolo,
C Cosco,
M Trapasso,
A Zingone,
P Malatesta,
N Perrotti,
D Tramontano,
and
PL Mattioli
Department of Experimental and Clinical Medicine, University of Reggio Calabria, Catanzaro, Italy.
OBJECTIVES: This study sought to evaluate the possible association of polymorphism of the angiotensin-converting enzyme (ACE) gene with blood pressure and left ventricular mass index (LVMI). BACKGROUND: The renin-angiotensin system seems to be involved in the pathogenesis of essential hypertension. Moreover, recent epidemiologic observations demonstrate that many subjects with left ventricular hypertrophy have normal blood pressure levels, suggesting that factors other than hemodynamic overload may contribute to the hypertrophy. METHODS: The study included 140 untreated hypertensive outpatients who underwent ambulatory blood pressure monitoring, echocardiographic evaluation and analysis for insertion (I)/ deletion (D) polymorphism in intron 16 of the ACE gene by polymerase chain reaction. Blood pressure was measured at 24 h, and LVMI was calculated by the Devereux formula, in each patient. RESULTS: Left ventricular mass index values (mean +/- SD) were 137 +/- 28 g/m2 in patients with the DD genotype, 125 +/- 27 g/m2 in those with the ID genotype and 115 +/- 27 g/m2 in those with II genotype. The frequencies of the DD, ID and II genotypes were 45.71% (n = 64), 46.42% (n = 65) and 7.85% (n = 11), respectively, and were in Hardy-Weinberg equilibrium. The strongest association between left ventricular mass and DD genotype in our cohort appeared to be an independent cardiovascular risk factor (DD vs. ID: odds ratio [OR] 2.497, 95% confidence interval [CI] interval 1.158 to 5.412, p < 0.05; DD vs. II: OR 6.577, 95% CI 1.169 to 28.580, p < 0.02). CONCLUSIONS: Our data show that the LVMI was significantly enhanced in patients with the DD genotype.
This article has been cited by other articles:

|
 |

|
 |
 
Yu Jin, T. Kuznetsova, L. Thijs, T. Richart, K. Stolarz-Skrzypek, Yanping Liu, R. Fagard, P. Manunta, G. Bianchi, and J. A. Staessen
Association of echocardiographic left ventricular structure with the ACE D/I polymorphism: a meta-analysis
Journal of Renin-Angiotensin-Aldosterone System,
September 1, 2011;
12(3):
243 - 253.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sciacqua, S. Miceli, G. Carullo, L. Greco, E. Succurro, F. Arturi, G. Sesti, and F. Perticone
One-Hour Postload Plasma Glucose Levels and Left Ventricular Mass in Hypertensive Patients
Diabetes Care,
June 1, 2011;
34(6):
1406 - 1411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Ginsburg, S. H. Shah, and J. J. McCarthy
Taking Cardiovascular Genetic Association Studies to the Next Level
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
930 - 932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Sayed-Tabatabaei, J. J. Houwing-Duistermaat, C. M. van Duijn, and J. C.M. Witteman
Angiotensin-Converting Enzyme Gene Polymorphism and Carotid Artery Wall Thickness: A Meta-Analysis
Stroke,
July 1, 2003;
34(7):
1634 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Volzke, J. Engel, V. Kleine, C. Schwahn, J. B. Dahm, L. Eckel, and R. Rettig
Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism and Cardiac Mortality and Morbidity After Coronary Artery Bypass Graft Surgery*
Chest,
July 1, 2002;
122(1):
31 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Perticone, R. Ceravolo, S. Iacopino, C. Cloro, G. Ventura, R. Maio, E. Gulletta, N. Perrotti, and P. L. Mattioli
Relationship between Angiotensin-Converting Enzyme Gene Polymorphism and Insulin Resistance in Never-Treated Hypertensive Patients
J. Clin. Endocrinol. Metab.,
January 1, 2001;
86(1):
172 - 178.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Okamura, M. Ohishi, H. Rakugi, T. Katsuya, Y. Yanagitani, S. Takiuchi, Y. Taniyama, K. Moriguchi, H. Ito, Y. Higashino, et al.
Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty
Angiology,
October 1, 1999;
50(10):
811 - 822.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Perticone, R. Maio, C. Cosco, R. Ceravolo, S. Iacopino, M. Chello, P. Mastroroberto, D. Tramontano, and P. L Mattioli
Hypertensive left ventricular remodeling and ACE-gene polymorphism
Cardiovasc Res,
July 1, 1999;
43(1):
192 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Perticone, R. Ceravolo, R. Maio, G. Ventura, A. Zingone, N. Perrotti, and P. L. Mattioli
Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Endothelium-Dependent Vasodilation in Never Treated Hypertensive Patients
Hypertension,
April 1, 1998;
31(4):
900 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Staessen Dr, G. Ginocchio, J. G. Wang, A. P. Saavedra, F. Soubrier, R. Vlietinck, and R. Fagard
Genetic Variability in the Renin-Angiotensin System: Prevalence of Alleles and Genotypes
European Journal of Cardiovascular Prevention & Rehabilitation,
October 1, 1997;
4(5-6):
401 - 422.
[Abstract]
[PDF]
|
 |
|
|